Discovery & Development

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Complex formulations bring complex technical challenges.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

PVP has a long pedigree of use in both medicinal and pharma applications – and innovations continue to emerge.

From core to coating, there is a lot to consider when it comes to developing and optimizing a solid dosage formulation.

Artificial Intelligence and other innovative technologies have the potential to disrupt every stage of the clinical trial process.

Transdermal patches coupled with jewelry offer a discreeet method of drug delivery.

Drug repurposing is in vogue, but it’s not always as easy as you think.

Could harnessing the power of artificial intelligence put an end to the leading cause of sight loss in the developed world?